Hearing aids may slow mental decline in those at higher risk of dementia, study finds
(By Lizzy Lawrence for STAT) Doctors have long suspected that hearing loss in older adults hastens dementia, the cognitive decline
Read More
An experimental Alzheimer’s drug outperforms one just approved by the FDA
(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read MoreUnderstanding the fundamentals of Medicare
A recent study by the Kaiser Family Foundation found that 22 percent of people ages 65 and up said they
Read MoreResearchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer’s
(By Andrew Joseph for STAT) When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that
Read MoreIn Older Adults, a Little Excess Weight Isn’t Such a Bad Thing
(By Judith Graham for KFF Health News) Millions of people enter later life carrying an extra 10 to 15 pounds,
Read MoreWill the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read MoreHealing invisible wounds: Revolutionary PTSD services
(Source – news.va.gov) In a world where physical wounds are often visible and readily addressed, the invisible scars left by
Read MoreMedicare Advantage’s growth spurt won’t last forever: McKinsey
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage enrollment has grown rapidly in recent years, now enrolling over half of
Read MorePayer price transparency data has been available for a year. Is it lowering costs?
(By Rylee Wilson for Becker’s Hospital Review) Price transparency data is available, but several changes are needed to actually bring
Read More10 Prescription Drugs Accounted for $48 Billion in Medicare Part D Spending in 2021, or More Than One-Fifth of Part D Spending That Year
(By Chris Lee for The Kaiser Family Foundation published July 12, 2023) A new KFF analysis finds that the 10
Read More